In summary, our MR analysis results suggest that the genetically predicted cathepsin H has an inhibitory effect on major subtypes of malignant skin tumors such as melanoma and CSCC, but further exploration is needed to understand its role in BCC. The gene discussed is CTSH; the disease is skin squamous cell carcinoma.